Clinical features of headache at altitude: A prospective study

Neurology

Volumn 60, Issue 7, 2003, Pages 1167-1171

  Silber, E ^a,b   Sonnenberg, P ^b   Collier, D J ^a   Pollard, A J ^c   Murdoch, D R ^d   Goadsby, P J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALTITUDE; ALTITUDE DISEASE; ARTICLE; CLINICAL FEATURE; FEMALE; HEADACHE; HUMAN; INCIDENCE; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; SPORT; WAKEFULNESS;

EID: 0037426424     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000055876.26737.B9     Document Type: Article

References (18)

1. Sharma VM, Malhotra MS, Baskaran AS. Variations in psychomotor efficiency during prolonged stay at high altitude. Ergonomics 1975;18:511-516.
2. Hackett PH, Rennie D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976;2:1149-1155.
3. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001;345:107-114.
4. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:1-96.
5. Hackett P, Oelz O. The Lake Louise Consensus on the Definition and Quantification of Altitude Illness. In: Sutton J, Coates CH, eds. Hypoxia and mountain medicine. Burlington: Queen City Printers, 1992:327-330.
6. Appenzeller O. Barogenic headache. In: Clifford Rose F, ed. Handbook of clinical neurology, 48(4). Amsterdam: Elsevier Science, 1986:395-404.
7. Bartsch P, Maggi S, Kleger GR, Ballmer PE, Baumgartner RW. Sumatriptan for high-altitude headache. Lancet 1994;344:1445.
8. Burtscher M, Likar R, Nachbauer W, Schaffert W, Philadelphy M. Ibuprofen versus sumatriptan for high-altitude headache. Lancet 1995;346:254-255.
9. Montgomery AB, Mills J, Luce JM. Incidence of acute mountain sickness at intermediate altitude. JAMA 1989;261:732-734.
10. Silber E. Upper limb motor function at 5000 metres: determinants of performance and residual sequelae. J Neurol Neurosurg Psychiatry 2000;69:233-236.
11. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993;118:587-592.
12. Pei SX, Chen XJ, Si Ren BZ, et al. Chronic mountain sickness in Tibet. Q J Med 1989;71:555-574.
13. Silberstein SD, Saper JR, Freitag FG. Migraine. Diagnosis and treatment. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's headache and other head pain. New York: Oxford University Press, 2001:121-237.
14. Murdoch DR. Focal neurological deficits and migraine at high altitude. J Neurol Neurosurg Psychiatry 1995;58:637.
15. Johnson TS, Rock PB. Current concepts. Acute mountain sickness. N Engl J Med 1988;319:841-845.
16. Olesen J. Revision of the International Headache Classification. Cephalalgia 2001;21:261.
17. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA 1998;280:1920-1925.
18. Roach RC, Maes D, Sandoval D, et al. Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 2000;88:581-585.